Business: Pharmaceutical

In this April 18, 2006 file photo, a woman leaves the Eli Lilly and Company campus in downtown Indianapolis.  Eli Lilly & Co. has agreed to spend more than $6 billion to fortify its cancer treatment portfolio by acquiring the biotechnology firm ImClone Systems Inc. in a deal that tops earlier offers from competitor Bristol-Myers Squibb Co. (AP Photo/Michael Conroy, file)

Eli Lilly settles Zyprexa inquiries in 32 states

AP - Tue Oct 7, 2:57 PM ET

INDIANAPOLIS - Drugmaker Eli Lilly & Co. cleared another legal cloud hanging over its top-selling drug Zyprexa when it announced a $62 million settlement Tuesday, but several other storms are still brewing for the antipsychotic medication.

  • Eli Lilly to buy ImClone for more than $6B AP - Mon Oct 6, 5:17 PM ET

    INDIANAPOLIS - Eli Lilly & Co.'s winning bid of more than $6 billion for cancer drugmaker ImClone Systems means a billion-dollar payday for former rival bidder Bristol-Myers and vindication for corporate raider and ImClone Chairman Carl Icahn.

  • The deal: Lilly buys ImClone AP - Mon Oct 6, 4:30 PM ET

    WHAT HAPPENED: Indianapolis-based drug maker Eli Lilly & Co. is buying the biotech firm ImClone Systems Inc. for more than $6 billion.

  • A laboratory researcher in a file photo. (File/Reuters)
    Eli Lilly bids $6.5 billion for ImClone Reuters - Mon Oct 6, 2:59 PM ET

    BOSTON/PHILADELPHIA (Reuters) - Eli Lilly and Co has agreed to acquire ImClone Systems Inc for $6.5 billion, outbidding Bristol-Myers Squibb Co and potentially bringing to a close one of the most colorful corporate sagas in biotech history.

  • US pharmaceutical company Eli Lilly said Monday it had agreed a takeover worth 6.5 billion dollars with biotech firm ImClone, which is also a target for rival Bristol-Myers Squibb (BMS).(ImClone)
    US cancer specialist at centre of 6.5-bln-dlr takeover battle AFP - Mon Oct 6, 9:34 AM ET

    WASHINGTON (AFP) - US pharmaceutical company Eli Lilly said Monday it had agreed a takeover worth 6.5 billion dollars with biotech firm ImClone, which is also a target for rival Bristol-Myers Squibb (BMS).

  • In this April 18, 2006 file photo, a woman leaves the Eli Lilly and Company campus in downtown Indianapolis.  The Wall Street Journal on Wednesday, Oct. 1, 2008 reported that drugmaker Eli Lilly & Co. is the secret suitor courting ImClone Systems Inc. and is offering approximately $6.1 billion for the biotech company.  (AP Photo/Michael Conroy, file)
    Eli Lilly in talks to buy ImClone: sources Reuters - Wed Oct 1, 9:33 PM ET

    PHILADELPHIA (Reuters) - ImClone Systems Inc is in talks to be acquired by Eli Lilly and Co , sources familiar with the situation said on Wednesday, after ImClone had rebuffed a sweetened takeover offer from Bristol-Myers Squibb Co .

  • Report: ImClone's secret suitor is Eli Lilly AP - Wed Oct 1, 9:21 PM ET

    INDIANAPOLIS - Drugmaker Eli Lilly & Co. reportedly is the secret suitor that's been courting ImClone Systems Inc. and is offering approximately $6.1 billion for the biotech company.

  • Congress targets rogue online pharmacies AP - Wed Oct 1, 1:30 PM ET

    WASHINGTON - Congress has passed a bill intended to crack down on rogue online pharmacies that sell drugs without a valid prescription.

  • Federal regulators delay Eli Lilly blood thinner AP - Fri Sep 26, 5:53 PM ET

    INDIANAPOLIS - Federal health regulators delayed a decision on a blood thinner from Eli Lilly for a second time Friday, raising concerns on Wall Street about the potential blockbuster medication.

  • Map locates cites in the U.S. where pharmaceuticals have been detected in drinking water supplies;
    Calif. warns people not to flush pharmaceuticals AP - Fri Sep 26, 3:27 AM ET

    LOS ANGELES - The state of California has a warning for its 36 million residents: Do not flush pharmaceuticals down the toilet or drain, or they may end up in a river near you.

  • A patient holds an Imigran Recovery tablet. A survey by the consumer watchdog Which? found that poorly-trained pharmacy staff are giving inappropiate and potentially dangerous medical advice to patients.(AFP)
    Service trumps price in pharmacy survey Reuters - Thu Sep 25, 9:57 AM ET

    CHICAGO (Reuters) - Retailers that have rolled out low-cost generic prescription programs cannot rely on cheaper drugs alone to lure customers, especially if they skimp on good service, a new J.D. Power and Associates survey found.

  • Lilly CEO forecasts drug maker's evolution AP - Wed Sep 24, 4:32 PM ET

    INDIANAPOLIS - Eli Lilly and Co. aims to grow leaner and more diverse as it pushes to keep pace with changes spreading through the drug industry, CEO John Lechleiter said in a Wednesday afternoon speech.

  • Drug maker plans to disclose payments to doctors AP - Wed Sep 24, 6:58 AM ET

    WASHINGTON - In an industry first, Eli Lilly and Co. says it will begin disclosing how much money it paid to individual doctors nationally for advice, speeches and other services.

  • The US Food and Drug Administration on Tuesday warned pharmaceutical laboratories to stop marketing two unapproved products that have been linked to serious health problems. The first is an eye solution used to irrigate the eyes during and following cataract surgery, and the second is an ointment to treat sores and ulcers containing papain, which is not FDA approved.(AFP/File/Karen Bleier)
    US orders halt to marketing of eye solution, ointment AFP - Tue Sep 23, 7:50 PM ET

    WASHINGTON (AFP) - The US Food and Drug Administration on Tuesday warned pharmaceutical laboratories to stop marketing two unapproved products that have been linked to serious health problems.

  • Sector Snap: Drug developers insulated from storm AP - Tue Sep 23, 2:28 PM ET

    NEW YORK - Big pharmaceutical companies and their biotech cousins will likely weather the financial crisis engulfing Wall Street, several analysts said, because of the necessity of their products and cash-rich balance sheets.

  • The sign at a Walgreens store is seen in Golden, Colorado, June 25, 2007. (Rick Wilking/Reuters)
    Walgreen may launch hostile offer for Longs Reuters - Mon Sep 22, 10:03 PM ET

    PHILADELPHIA (Reuters) - Walgreen Co said on Monday it may launch a hostile takeover for Longs Drug Stores Corp if its smaller pharmacy chain rival fails to open merger talks.

  • Pfizer retooling, pushing emerging market sales AP - Mon Sep 22, 4:54 PM ET

    TRENTON, N.J. - Pfizer Inc. is dramatically stepping up sales efforts in emerging markets, overhauling U.S. business operations and slashing more costs ahead of the 2011 patent loss for cholesterol blockbuster Lipitor, its head of pharmaceutical operations said Monday.

  • A General view of the packaging area is seen at the warehouse of a pharmaceutical company, September 20, 2006. (Regis Duvignau/Reuters)
    Home delivery pharmacies seen to boost generic use Reuters - Thu Sep 18, 12:27 AM ET

    NEW YORK (Reuters) - Patients are more likely to choose a money-saving generic drug over more expensive branded medicines when using a home delivery pharmacy instead of a retail drug store, according to a study by Express Scripts Inc.

  • Indian laboratory researchers conduct tests at the Ranbaxy Laboratories in 2003. The US Food and Drug Administration Tuesday said it would block the import of more than 30 generic drugs made by Indian pharmaceutical company Ranbaxy, saying the company had failed to meet manufacturing standards.(AFP/File/Sebastian D'souza)
    Ranbaxy vows to resolve US import ban on generics AP - Wed Sep 17, 4:53 AM ET

    MUMBAI, India - India's largest pharmaceutical company, Ranbaxy Laboratories, said Wednesday that it will resolve problems that led the U.S. Food and Drug Administration to ban the import of more than 30 of its generic drugs.

  • Chinese Vice Premier Wang Qishan, pictured in June 2008. The United States and China have announced a raft of trade agreements, including health care and pharmaceutical products, at the end of one-day bilateral trade talks in California.(AFP/File/Nicholas Kamm)
    US, China announce agreements after bilateral trade talks AFP - Wed Sep 17, 12:28 AM ET

    YORBA LINDA (AFP) - The United States and China announced Tuesday a raft of trade agreements, including health care and pharmaceutical products, at the end of one-day bilateral trade talks in California.

  • FDA blocks imports from India's generic drug giant AP - Tue Sep 16, 6:12 PM ET

    WASHINGTON - The government closed U.S. borders Tuesday to more than 30 generic drugs — including popular antibiotics and cholesterol medicines — made by India's biggest pharmaceutical company, citing poor quality in two of its factories.

  • Bryant Sears, working in a Teflon suit and wearing goggles and rubber gloves, sorts leftover medicines and contaminated packing one-by-one at Abbott Northwestern Hospital, May 13, 2008 in Minneapolis. Items are put into separate barrels and bins, depending on their differing disposal standards and methods. (AP Photo/Jim Mone)
    AP IMPACT: Tons of drugs dumped into wastewater AP - Sun Sep 14, 2:18 PM ET

    U.S. hospitals and long-term care facilities annually flush millions of pounds of unused pharmaceuticals down the drain, pumping contaminants into America's drinking water, according to an ongoing Associated Press investigation.

  • J&J Vice Chairman Poon to retire in March Reuters - Fri Sep 12, 8:21 AM ET

    NEW YORK (Reuters) - Johnson & Johnson's board vice chairman, Christine Poon, who also is worldwide chairman of its pharmaceuticals group, will retire from the company and the board on March 1.

  • Kathy Nelson, owner of the drug store in Arthur, N.D., demonstrates the computer and camera that pharmacy technicians use to communicate with pharmacists on prescriptions. Aug. 31, 2008. (AP Photo/Dave Kolpack)
    ND telepharmacy project expands across country AP - Fri Sep 12, 6:47 AM ET

    ARTHUR, N.D. - As recently as three years ago, many elderly residents in this part of southeastern North Dakota were forced to order their medications by mail.

  • AP Enterprise: Drugs affect more drinking water AP - Fri Sep 12, 4:26 AM ET

    Testing prompted by an Associated Press story that revealed trace amounts of pharmaceuticals in drinking water supplies has shown that more Americans are affected by the problem than previously thought — at least 46 million.

  • An official stands in front of anti-doping control after the twelfth stage of the 95th Tour de France cycling race between Lavelanet and Narbonne, July 17, 2008. (Regis Duvignau/Reuters)
    NY judge drops steroid case against Fla. pharmacy AP - Thu Sep 11, 6:02 PM ET

    ALBANY, N.Y. - A New York judge threw out an indictment against five operators of a Florida pharmacy targeted almost two years ago in an investigation of illegal steroid sales over the Internet and by phone.

  • AP Enterprise: Report prompts more water tests AP - Thu Sep 11, 3:43 PM ET

    At least 46 million Americans are supplied drinking water that has tested positive for trace concentrations of pharmaceuticals, an increase from the 41 million people reported by The Associated Press in March.

  • FDA cites brain virus with Genentech, Biogen drug AP - Thu Sep 11, 2:40 PM ET

    WASHINGTON - Federal regualtors said Thursday one case of a deadly brain infection has been reported in a patient taking Genentech and Biogen Idec's blockbuster arthritis and cancer drug Rituxan.

  • Medical schools, journals fight industry influence AP - Thu Sep 11, 7:18 AM ET

    TRENTON, N.J. - Just about every segment of the medical community is piling on the pharmaceutical industry these days, accusing drugmakers of deceiving the public, manipulating doctors and putting profits before patients.

  • Carl Icahn, the billionaire investor and chairman of ImClone's board, in a file photo. (Chip East/Reuters)
    ImClone says it received $70-a-share buyout offer Reuters - Wed Sep 10, 12:30 PM ET

    BOSTON (Reuters) - ImClone Systems Inc said on Wednesday it has received a takeover offer of $70 a share from a large pharmaceutical company, topping an earlier bid of $60 a share from Bristol-Myers Squibb Co and sending its shares up 7 percent.

1  2    Next